Fingerprint
Dive into the research topics of 'Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins
Monika A. Davare, Anna Saborowski, Christopher A. Eide, Cristina Tognon, Rebecca L. Smith, Johannes Elferich, Anupriya Agarwal, Jeffrey W. Tyner, Ujwal P. Shinde, Scott W. Lowe, Brian J. Druker
Research output: Contribution to journal › Article › peer-review
105
Scopus
citations